Growblox Sciences Inc (OP: GBLX )
0.0950 USD +0.0100 (+11.76%) Streaming Delayed Price Updated: 12:57 PM EST, Feb 24, 2021 Add to My Watchlist
Press releases about Growblox Sciences Inc
Legal and Medical Cannabis Industries Are Set to Grow
March 22, 2018
Legal Cannabis Industry Utilizes Reward Based Programs
March 15, 2018
GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce their sponsorship of the 1st Annual "Innovation in Medical Cannabis Therapies" Symposium in Las Vegas, Nevada, on Friday, June 1st, 2018. Top...
Legal Cannabis and CBD Sales are on the Rise
March 02, 2018
Sales of Legal Cannabis Products Continues to Accelerate
February 27, 2018
GB Sciences, Inc. Enters A New Market by Signing a Contract Farming Agreement for the Development of Boutique Hemp Genetics with the Colorado Hemp Project
February 26, 2018
GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce a new agreement with the Colorado Hemp Project to develop and cultivate boutique genetics and new strains of hemp which will provide the key...
Legal Cannabis Market Projected to Grow With Consumer Spending
February 22, 2018
GB Sciences Receives Issuance of Its Cannabis Oil Production License
February 20, 2018
GB Sciences enters full commercial operations with its cannabis oil production partners Cura Cannabis Solutions and RWH, a new venture co-founded by Deliciously Dee™
GB Sciences Partners with Wellcana Group, LLC. in the Development of Medical Cannabis in Louisiana
February 13, 2018
GB Sciences, Inc. (OTCQB: GBLX) and its wholly-owned subsidiary GB Sciences Louisiana, LLC. (GBSL) are pleased to announce the completion of a new agreement with Wellcana Group, LLC. (Wellcana) to work...
Research Shows the Growth of Legal Cannabis Sales
February 08, 2018
GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More
February 04, 2018
GB Sciences, Inc. (OTCQB: GBLX) has filed a nonprovisional patent application to protect its cannabinoid-containing complex mixtures for the treatment of inflammatory disorders. The new patent...
Legal Cannabis Market Growth in North America
February 02, 2018
GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board
January 25, 2018
GB Sciences, Inc. (OTCQB: GBLX) welcomes Dr. Zoltan Mari, Section Head of the Nevada Movement Disorders Program and Lee Pascal Parkinson's Disease Scholar at Cleveland Clinic Lou Ruvo Center for Brain...
Legal Cannabis Market Expected to Grow Because of Continued Adoption
January 25, 2018
Cannabis Sales Projected to Increase as California Paves the way for Recreational use
January 19, 2018
From EIN Presswire
GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains
January 07, 2018
Effective medicines start with quality ingredients. GB Sciences has developed controlled growth environments and methods to amplify the yield of important raw materials for its medical formulations.
Cannabis Industry to Grow With Expanding Legal Sales
January 05, 2018
Cannabis Stocks Expand North American Operations Anticipating Strong 2018 as a Result of Latest Legalization Milestones
January 03, 2018
Data Shows Positive Signs for the Legal Cannabis Industry
December 29, 2017
GB Sciences' Chief Science Officer, Dr. Andrea Small-Howard, Has Been Invited to Join the Medical Cannabis in Neuroscience Panel at The Neuroscience Innovation Forum for BD&L and Investment in Therape
December 25, 2017
GB Sciences, Inc. (OTCQB: GBLX) will be represented on the Medical Cannabis in Neuroscience Panel at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology to take...
Legal Cannabis Market Shows Strength in Sales
December 19, 2017
Medical Cannabis Sales Increase as Legalization Spreads in the USA
December 14, 2017
GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits
December 12, 2017
Pot Stocks Gearing Up for Strong 2018 as Cannabis CBD Frenzy Intensifies
December 12, 2017
Uptick Newswire “Stock Day” Interviews John Poss CEO of GB Sciences on the Company’s Cannabis Tiers, Medical and Recreational
December 11, 2017
Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has interviewed hundreds of CEO’s within the micro-cap...
GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation
December 04, 2017
GB Sciences, Inc. (OTCQB: GBLX) explains that 100% of the mother plants (a plant that in its vegetative state does not produce flowers but only branches and leaves) in their Las Vegas cultivation...